These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 31693237

  • 1. An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia.
    Noda H, Guo J, Khatri A, Dean T, Reyes M, Armanini M, Brooks DJ, Martins JS, Schipani E, Bouxsein ML, Demay MB, Potts JT, Jüppner H, Gardella TJ.
    J Bone Miner Res; 2020 Mar; 35(3):540-549. PubMed ID: 31693237
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia.
    Schipani E, Langman C, Hunzelman J, Le Merrer M, Loke KY, Dillon MJ, Silve C, Jüppner H.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3052-7. PubMed ID: 10487664
    [Abstract] [Full Text] [Related]

  • 4. The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.
    Calvi LM, Schipani E.
    J Endocrinol Invest; 2000 Sep; 23(8):545-54. PubMed ID: 11021773
    [Abstract] [Full Text] [Related]

  • 5. A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation.
    Bastepe M, Raas-Rothschild A, Silver J, Weissman I, Wientroub S, Jüppner H, Gillis D.
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3595-600. PubMed ID: 15240651
    [Abstract] [Full Text] [Related]

  • 6. Progression of Mineral Ion Abnormalities in Patients With Jansen Metaphyseal Chondrodysplasia.
    Saito H, Noda H, Gatault P, Bockenhauer D, Loke KY, Hiort O, Silve C, Sharwood E, Martin RM, Dillon MJ, Gillis D, Harris M, Rao SD, Pauli RM, Gardella TJ, Jüppner H.
    J Clin Endocrinol Metab; 2018 Jul 01; 103(7):2660-2669. PubMed ID: 29788189
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Jansen's metaphyseal chondrodysplasia: a disorder due to a PTH/PTHrP receptor gene mutation.
    Jüppner H.
    Trends Endocrinol Metab; 1996 Jul 01; 7(5):157-62. PubMed ID: 18406742
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors.
    Gardella TJ, Luck MD, Jensen GS, Schipani E, Potts JT, Jüppner H.
    Endocrinology; 1996 Sep 01; 137(9):3936-41. PubMed ID: 8756569
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with Jansen's metaphyseal chondrodysplasia.
    Onuchic L, Ferraz-de-Souza B, Mendonca BB, Correa PH, Martin RM.
    J Clin Endocrinol Metab; 2012 Apr 01; 97(4):1098-103. PubMed ID: 22278430
    [Abstract] [Full Text] [Related]

  • 15. Jansen-type metaphyseal chondrodysplasia: analysis of PTH/PTH-related protein receptor messenger RNA by the reverse transcriptase-polymerase chain method.
    Minagawa M, Arakawa K, Takeuchi S, Minamitani K, Yasuda T, Niimi H.
    Endocr J; 1997 Aug 01; 44(4):493-9. PubMed ID: 9447281
    [Abstract] [Full Text] [Related]

  • 16. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
    Jobert AS, Zhang P, Couvineau A, Bonaventure J, Roume J, Le Merrer M, Silve C.
    J Clin Invest; 1998 Jul 01; 102(1):34-40. PubMed ID: 9649554
    [Abstract] [Full Text] [Related]

  • 17. Mice expressing a constitutively active PTH/PTHrP receptor in osteoblasts show reduced callus size but normal callus morphology during fracture healing.
    Marsell R, Jonsson KB, Cho TJ, Einhorn TA, Ohlsson C, Schipani E.
    Acta Orthop; 2007 Feb 01; 78(1):39-45. PubMed ID: 17453391
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Receptors for PTH and PTHrP: their biological importance and functional properties.
    Mannstadt M, Jüppner H, Gardella TJ.
    Am J Physiol; 1999 Nov 01; 277(5):F665-75. PubMed ID: 10564229
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.